IDXG

INTERPACE BIOSCIENCES, INC.

Healthcare · Diagnostics & Research

$97.94 sample

+1.26 (+1.30%) 1D

Market cap

$466.3B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-13

Alerts

8

Price$97.94 -1.32% 3M daily closessample

110.4296.68

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13SECDEF 14A filed
Oct 08INSInsider sell: General Counsel
Oct 01SECDEF 14A filed
Sep 23INSInsider buy: 10% owner
Sep 15SEC8-K filed: material event
Sep 09INSInsider sell: EVP, Operations
Sep 03INSInsider sell: 10% owner
Aug 25SEC10-Q filed

Sign up to see the real IDXG record →

Company facts

SEC EDGAR registration

Name: INTERPACE BIOSCIENCES, INC.
Sector: Healthcare
Industry: Diagnostics & Research
Smart-money score: -32sample, -100 to +100
Reporting currency: USD

Who is positioning in IDXG

sample

Insiders: 29 insider transactions over 90 days, net selling, $251.3M
Congress: 5 members traded over 90 days
Institutions · 13F: 35 funds hold $4.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$16.7B +23.2% y/y

Q4 2024Q3 2026

Inventory$9.7B +8.9% y/y

Q4 2024Q3 2026

Accounts receivable$7.5B +13.8% y/y

Q4 2024Q3 2026

Total debt$20.1B +13.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $410.6B -9.2% 3M
Sample peer B: $157.2B -1.4% 3M
Sample peer C: $249.9B +5.9% 3M
Sample peer D: $80.3B -13.4% 3M
Sample peer E: $195.0B -7.5% 3M